General American Investors CO Inc Intra Cellular Therapies, Inc. Transaction History
General American Investors CO Inc
- $1.4 Billion
- Q1 2024
A detailed history of General American Investors CO Inc transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, General American Investors CO Inc holds 260,439 shares of ITCI stock, worth $17.5 Million. This represents 1.29% of its overall portfolio holdings.
Number of Shares
260,439
Previous 260,439
-0.0%
Holding current value
$17.5 Million
Previous $18.7 Million
3.38%
% of portfolio
1.29%
Previous 1.47%
Shares
8 transactions
Others Institutions Holding ITCI
# of Institutions
382Shares Held
77.7MCall Options Held
1.7MPut Options Held
1.13M-
Vanguard Group Inc Valley Forge, PA9.23MShares$620 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.08MShares$543 Million0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.85MShares$259 Million1.4% of portfolio
-
Bellevue Group Ag Kuesnacht, V82.82MShares$190 Million3.06% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.48MShares$166 Million2.06% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $6.35B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...